Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Pancreatic Neoplasms 14Breast Neoplasms 10Thyroid Nodule 5Thyroid Neoplasms 5Lymphoma 5Disease 4Head and Neck Neoplasms 3Uveal Melanoma 2Neoplasm Metastasis 2Melanoma 2Gastrointestinal Stromal Tumors 2Uveal Neoplasms 1Sarcoma, Ewing 1Sarcoidosis 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Peutz-Jeghers Syndrome 1Pancreatitis, Chronic 1Pancreatic Cyst 1Neoplastic Cells, Circulating 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphadenopathy 1Lung Neoplasms 1Iris Neoplasms 1Focus: Breast Cancer With Axillary Node Metastasis 1Fanconi Anemia, Complementation Group D1 1Esophagus 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 25Temozolomide 22Vincristine 18Irinotecan 18Doxorubicin 13Topotecan 10Melphalan 10Etoposide 10Ifosfamide 8Busulfan 8cabozantinib 7Magnetic Resonance Spectroscopy 7Granulocyte Colony-Stimulating Factor 7Filgrastim 6regorafenib 5fludarabine 5X-Rays 5Specimen Handling 5Sirolimus 5Radiotherapy 5Gemcitabine 5Drug Therapy 5pegfilgrastim 4palbociclib 4liposomal doxorubicin 4irinotecan sucrosofate 4ganitumab 4fludarabine phosphate 4Trabectedin 4Phantoms, Imaging 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Biopsy, Fine-Needle × Clear all
NCT05042934 2022-02-10

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡